Nuvation Bio Inc. Class A Common Stock vs ONEOK Inc. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B), while ONEOK Inc. Common Stock trades at $90.5 (market cap $56.92B). The key difference: ONEOK Inc. Common Stock is far larger — about 32.7× Nuvation Bio Inc. Class A Common Stock's market cap, and ONEOK Inc. Common Stock pays a 4.74% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and ONEOK Inc. Common Stock for 0 Days on average.
| NUVB | OKE | |
|---|---|---|
Market Cap | $1.74B | $56.92B |
Volume | 9,289,619 | 5,022,596 |
Sector | Health | Energy |
52-Week High | $9.54 | $97.51 |
52-Week Low | $3.41 | $64.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.33B | $89.78B |
Dividend Yield | — | 4.74% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →ONEOK operates energy infrastructure for natural gas, natural gas liquids, and crude oil. Its assets include pipelines, processing facilities, storage, and related services.
Read more on OKE →